MoAb-induced apoptosis, but did not influence DEX-induced peripheral T lymphocytes. This process is inhibited by a cell death. Furthermore, the decrease appeared to be related number of growth factors, including interleukin-2 (IL-2), ILto the expression of Fas/APO-1 (CD95) and Fas-ligand (Fas-3, and IL-4, as well as by triggering of the adhesion molecule L). In fact, we show that CD2 stimulation inhibits apoptosis CD44, which would indicate that signals generated by memby preventing the CD3-induced upregulation of Fas and Fasbrane receptors can modulate the survival of lymphoid cells.
A tion with LFA-3 (CD58), in facilitating CD3/TCR recogni-POPTOSIS (PROGRAMMED cell death) is a common mechanism often triggered by environmental stimuli. [1] [2] [3] [4] tion of the antigens presented via the major histocompatibilIt is operative in tissue remodeling and involution during ity complex (MHC) and in T-cell activation. [34] [35] [36] [37] Moreover, embryogenesis, control of cell growth in adult life, various CD2 activation regulates expression of interleukin-2 (IL-2), degenerative diseases of the central nervous system, and IL-2 receptor-a, and transcription of HLA-DR and IL-6 regulation of neoplastic cell growth.
5-8 Apoptosis involves a genes and induces transcription factors that bind to the NFcascade of specific biochemical and morphologic events. The AT, AP-1, and NF-kB sites. [38] [39] [40] Recently, it has been remost significant of these is activation of endogenous endonuported that in vivo administration of anti-CD2 or anti-CD48 cleases, which are responsible for internucleosomal DNA MoAbs inhibits the T-cell response in mice and rats. [41] [42] [43] fragmentation.
9,10
Recent evidence that AICD could be a peripheral negative Apoptosis is also important in T-cell repertoire developselection mechanism 28 and that adhesion molecules play a ment. [11] [12] [13] These cells are controlled by a complex process role in controlling programmed cell death 44, 45 prompted us that includes both positive and negative selection. Negative to study the role of CD2 in AICD. We used three models: selection is the result of apoptosis activated through Ag-T-(1) a mouse hybridoma T-cell line (3DO) that undergoes cell receptor (TCR) interaction.
14 It has been suggested that apoptosis by TCR cross-linking and in which Fas/Fas-L inglucocorticoid hormones (GCH) and cytokines are also crititeraction plays a dominant role in mediating AICD, 46 (2) a cal regulators of T-cell death.
10, [15] [16] [17] [18] Mutual exclusion be-T-helper cell clone, and (3) primary polyclonal lymphocytes. tween two apoptosis inducers, namely anti-CD3 monoclonal Our results clearly show that CD2 stimulation by MoAbs antibodies (MoAbs) and dexamethasone (DEX), has also protects T cells from TCR/CD3-induced apoptosis, but does been described in a T-cell hybridoma. 19 not influence DEX-induced apoptosis. This protection was Recent evidence suggests that susceptibility to apoptosis associated with a decrease in Fas and Fas-L expression. is not restricted to immature or transformed T cells because Therefore, CD2 may be involved in the control of T-cell it can be triggered in vivo and in vitro in mature peripheral T activation and survival by modulating TCR-induced Fas and cells through Ag engagement of TCR/CD3. 20, 21 In particular, Fas-L expression. engagement of the TCR/CD3 complex of primary T cells,
MATERIALS AND METHODS
either by antigen-presenting cells (APCs) presenting antigenic peptide or antibody to TCR/CD3, triggers a series of Animals activation events, whereas CD3-stimulation of previously C3H/HeN mice purchased from Charles River (Chalco, Milan, activated T cells or hybridoma cell lines induces apoptosis.
Italy) were used at the age of 8 weeks as donors of T cells.
This process has been termed activation-induced cell death (AICD was measured by flow cytometry as described elsewhere. 50 After To block anti-CD3-induced apoptosis, in selected experiments culturing, cells were centrifuged and the pellets were gently resusanti-Fas MoAb (clone Jo2) or isotype-matched hamster antimouse pended in 1.5 mL hypotonic propidium iodide solution (PI; 50 mg/ IgG MoAb (clone UC8-4B3; Pharmingen) was used in soluble nonmL in 0.1% sodium citrate plus 0.1% Triton X-100; Sigma). The cross-linked form. For this purpose, the MoAbs were added after tubes were kept overnight at 4ЊC in the dark. The PI fluorescence the incubation of anti-CD3 pretreated plates with 100 mL/well FCS.
of individual nuclei was measured by flow cytometry using standard Lymph node T cells at the concentration of 2 1 10 5 cells/well were FACScan equipment (Becton Dickinson). The nuclei traversed a cultured for 5 days in the presence of 100 U/mL IL-2 49 (Genzyme, 488-nm Argon laser light beam. A 560-nm dichroid mirror (DM Cambridge, MA). 570) and a 600-nm band pass filter (band width, 35 nm) were used to collect the red fluorescence due to PI DNA staining, and the data
IL-2 and Proliferation Assays
were recorded in logarithmic scale in a Hewlett Packard (HP 9000, model 310; Palo Alto, CA) computer. The percentage of apoptotic Supernatants from cells stimulated with anti-CD3 and/or anti-CD2 for 20 hours were tested for their concentration of IL-2 by two-site cell nuclei (subdiploid DNA peak in the DNA fluorescence histogram) was calculated with specific FACScan research software (Lyenzyme-linked immunosorbent assay (ELISA) using MoAb JES6-1A12 as the primary reagent and biotinylated monoclonal S4B6 as sis II). Apoptosis evaluation by fluorescein (terminal deoxynucleotidyl the secondary reagent. Both antibodies were purchased from Pharmingen. The IL-2 titer (mean { SD of replicate samples) was extransferase [TdT] assay). A kit based on labeling of DNA strand breaks (Boehringer Mannheim, Milan, Italy) was used to detect and pressed as picograms per milliliter, calculated by reference to standard curves constructed with known amounts of IL-2. The sensitivity quantify apoptosis. 51 Cells were washed twice in PBS containing 1% bovine serum limit was approximately 20 pg/mL.
In some wells, [ 3 H]-thimidine (1 mCi/well) was added 12 hours albumin at 4ЊC, adjusted to 1 1 10 7 cells/mL, and then transferred into a U-bottomed 96-well plate. A paraformaldehyde solution (4% before harvesting and proliferation assayed as described elsewhere. and at the higher dose used for anti-CD2, had no effect ( MoAbs in a dose-dependent manner (Fig 2) . triggering. The data in Table 1 show that treatment with anti-CD2 MoAbs countered the decrease in cell number and Cytotoxicity Assay thymidine uptake due to anti-CD3-induced apoptosis. Furthermore, Table 1 shows that T-cell activation markers, such The results suggest that CD2-triggering may result in surdescribed. 24 Spontaneous release or release in the presence of antivival of lymphocytes exposed to anti-CD3 apoptotic stimuli.
CD3 and/or anti-CD2 with no effector cells was°15% of the total release. The percentage of specific lysis at various E:T ratios was for statistical evaluation.
CD2 Stimulation Does Not Inhibit DEX-Induced Apoptosis

CD2-Induced Inhibition of CD3-Activated Apoptosis
RESULTS
Correlates With Modulation of Fas and Fas-L Stimulation of CD2 Inhibits CD3-Driven Apoptosis
It has been suggested that T-cell AICD is also dependent on Fas/Fas-L interaction. Our results show that this system Treatment with anti-CD3 MoAbs mimics the effect of Ag-TCR/CD3 interaction. Previous reports indicate that antiis involved in AICD of 3DO cells. In fact, in experiments with soluble (non-cross-linked) anti-Fas MoAbs, there was CD2 antibodies increase in vitro or decrease in vivo CD3-induced activation. 35, 36, [41] [42] [43] We used a CD3 / CD2 / T-cell a substantial dose-dependent inhibition of anti-CD3-induced apoptosis, whereas no effect was observed with conhybridoma subline, 3DO, and a nontransformed T-cell clone, HDK-1, to analyze the effect of CD2 on apoptosis induced trol antibody (Fig 4) . We examined the expression of Fas/Fas-L in anti-CD3-and/or anti-CD2-treated cells to determine if they were involved in the effects mediated by anti-CD2 stimulation. Results (Fig 5) show that anti-CD2 MoAb treatment of 3DO or HDK-1 cells inhibited the anti-CD3-induced upregulation (Fig 5A and B) , but did not change the DEX-induced downmodulation of Fas expression in 3DO cells (Fig 6) .
Treatment with anti-CD2 alone did not modulate Fas expression (Figs 5 and 6).
To further analyze the effects of CD2 on apoptosis induced by CD3 MoAbs, we evaluated the levels of Fas by immunoprecipitation experiments. Results (Fig 7) show that CD3 triggering increases Fas expression in 3DO cell line and that this increase is countered by CD2 (compare lane 5 with lane 3).
We also evaluated the effects of treatment with anti-CD2 MoAbs on Fas-L expression in untreated and anti-CD3-treated 3DO cells. Expression of Fas-L was assessed by FACScan and functional analysis using 51 Cr-labeled P815 as a target population. 24 An antibody that recognizes an epitope located on the extracellular portion of the Fas-L molecule was used in flow cytometry analysis. In agreement with previous reports, 23, 24 the results show that anti-CD3 activation induced surface expression of Fas-L. CD2 stimulation decreased this anti-CD3-induced expression of Fas-L (Fig 8A,  top panel) .
To exclude that CD2 stimulation could simply affect cell surface Fas-L expression by increasing its shedding, 33 an aliquot of anti-CD3-and/or anti-CD2-triggered 3DO cells For personal use only. on April 13, 2017 . by guest www.bloodjournal.org From there was a difference between the group stained with the secondary antibody alone (background) and the group stained with Fas-L plus antirabbit antibody. This false-positive may represent the nonspecific staining inherent in the system. 52 The effect of CD2 engagement was also evident when Fas-L expression was evaluated as the ability to induce cytotoxicity in a Fas-L-sensitive target, P815, in a 51 Cr-release assay. Lysis of the target cells was observed after 16 hours of incubation, when 3DO cells were activated with anti-CD3 antibody. Killing was not detected in the control group or in the group treated with anti-CD2 alone. Significant inhibition of the lysis was observed when the cells were treated with both antibodies (Fig 8B) .
Similar results were obtained with normal lymphocytes. As previously reported, chronic stimulation is required for the Fas-L expression and apoptosis induction in primary lymphocytes. 49, 53 In fact, as shown in Fig 9, anti-CD3 stimulation induced cell death only after 5 days of culture, when Fas was upregulated and Fas-L was induced. This effect was partially reverted by CD2 ligation (Fig 9) .
Taken together, these results indicate that anti-CD2-induced protection correlates with downmodulation of Fas and Fas-L expression induced by TCR-triggering.
CD2-Stimulation Does Not Rescue 3DO Cells From Anti-Fas-Induced Apoptosis
To determine whether CD2 could inhibit apoptosis induced by ligation of Fas, 3DO cells were treated with agonist anti-Fas MoAbs and then plated on wells coated with an duced death of hybridoma T cells (Fig 10) , suggesting that (Fig 8A, bottom panel) conAg-induced extrathymic tolerance is reached by elimination of mature T cells in peripheral lymphoid organs. 20, 21, 54 firmed those of extracellular staining. We assume that the control group was negative for intracellular Fas-L, although Clonal activation and/or expansion is due to a balance be- tween apoptotic and activating signals and it has been proposed that AICD serves to limit the expansion of an immune response by eliminating lymphocytes that are no longer needed. 28 Several studies have shown that one of the key events in AICD is the expression and interaction of Fas/Fas-L and that interference with the Fas/Fas-L system inhibits TCR-mediated apoptosis. [23] [24] [25] 27, 30 Therefore, Fas/Fas-L is one of the systems by which specific clonal expansion is self-controlled. For personal use only. on April 13, 2017 . by guest www.bloodjournal.org From Our aim was to determine whether CD2 could control the levels of AICD. We used a T-cell hybridoma in which AICD is mediated by Fas/Fas-L interaction 46 (Fig 4) and compared the results with those obtained using a nontransformed CD3 /
CD2
/ T-cell clone. Murine T-cell hybridomas are considered to be a useful experimental model for studying apoptotic mechanisms because they undergo apoptosis after TCR triggering so mimicking the physiologic process of clonal deletion. Hybridomas, as well as previously activated T cells, Because costimulatory signals delivered by the interaction of T-cell surface receptors with their ligands on antigen presenting cells are required for antigen-specific T-cell activation 55, 56 and because overlapping signal transduction pathways are involved in both apoptotic and proliferative events, it is reasonable to suggest that costimulatory molecules play respond to signals delivered by TCR with cell suicide and/ Although the in vivo importance of our results remains to be established, these data suggest that CD2 may be involved or fratricide cell death.
19,58, 59 Our results indicate that CD2 stimulation by anti-CD2 not only in the physiologic control of T-cell activation, but also in modulating lymphocyte death. This protective activMoAbs leads to a substantial dose-dependent inhibition of TCR-induced apoptosis, as evaluated by the flow cytometry ity could be important in terms of immunologic memory by contributing to the survival of CD2 / immune T cells. In fact, assay with PI-labeled cells and TdT assay (Figs 1 and 2 ). CD2-induced rescue from AICD correlated with a decrease although previously activated T cells are susceptible to Fasmediated apoptosis, only a portion of these cells undergo of Fas and Fas-L expression induced by CD3 triggering (Figs 5, 7, and 8). Similar results were obtained using primary AICD. 22 This would suggest that APC provide a critical costimulatory signal(s) that can modulate Fas/Fas-L and lymphocytes after 5 days of chronic stimulation, when they upregulate Fas and express Fas-L (Fig 9) . Furthermore, in therefore control the level of AICD. We suggest that one of these APC-derived signals could be delivered by CD2 agreement with previous results, 42 our data show that CD2 decreases 3DO activation evaluated by IL-2 production and triggering. This CD2-mediated effect may also have some clinical IL-2R expression (Table 1) . These results suggest that activation and deletion pathways may share common mediators.
relevance. Results obtained with lpr and gld mice suggest that autoimmune diseases could be mediated by a defect of However, CD2 did not rescue 3DO cells from Fas-induced cell death (Fig 10) , suggesting that CD2 could interfere with Fas-induced apoptosis, 64 and the involvement of the Fas/Fas-L system in human diseases is worthy of investigation. In the CD3-, but not with the Fas-signal transduction pathway. The inhibition of CD3-induced expression of Fas/Fas-L particular, Fas antigen is found on various lymphoma and leukemia cells as well as on lymphoblastoid cells transcould be the mechanism responsible for the CD2-mediated effect. Based on studies performed on cell models in which formed with human T-lymphotropic virus type 1 (HTLV-1) or Epstein-Barr virus. 65 Moreover, recent findings suggest T-cell activation is induced by CD3 and/or CD2 triggering, [36] [37] [38] 40 it can be hypothesized that an interaction at the that an abnormal Fas-mediated cell death could be involved membrane level is responsible for the inhibition of in the pathogenesis of acquired immunodeficiency synapoptosis.
60,61 However, this effect could also be due to moddrome. 66 Therefore, the modulation of the Fas/Fas L system ulation of the kinases activated by TCR triggering 62 or to a may represent a target for new therapeutic strategies. direct control of Fas /Fas-L expression at the transcription or posttranscription level. To assess if the phenomenon studied
